nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—Isoprenaline—MAPK1—melanoma	0.0183	0.808	CrCbGaD
Levonordefrin—Epinephrine—TNF—melanoma	0.00436	0.192	CrCbGaD
Levonordefrin—ADRA2C—Signaling Pathways—HIF1A—melanoma	0.000155	0.000158	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CB—melanoma	0.000154	0.000158	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PDGFRA—melanoma	0.000154	0.000157	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—AKT1—melanoma	0.000153	0.000157	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—PIK3CA—melanoma	0.000152	0.000156	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FN1—melanoma	0.000152	0.000156	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PRKCA—melanoma	0.000152	0.000156	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ITGB3—melanoma	0.000152	0.000156	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CD86—melanoma	0.000152	0.000155	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—CXCL8—melanoma	0.000152	0.000155	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EDN1—melanoma	0.000151	0.000154	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOTCH1—melanoma	0.000149	0.000153	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SPP1—melanoma	0.000149	0.000153	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAP2K2—melanoma	0.000149	0.000152	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—CXCL8—melanoma	0.000148	0.000152	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KDR—melanoma	0.000148	0.000151	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TP53—melanoma	0.000147	0.000151	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CSF2—melanoma	0.000147	0.000151	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGF1—melanoma	0.000147	0.000151	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CD80—melanoma	0.000146	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CG—melanoma	0.000146	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APC—melanoma	0.000146	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—KIT—melanoma	0.000146	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—NRAS—melanoma	0.000146	0.000149	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—IL2—melanoma	0.000145	0.000148	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—E2F1—melanoma	0.000144	0.000148	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EGF—melanoma	0.000144	0.000147	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CB—melanoma	0.000143	0.000147	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CD—melanoma	0.000143	0.000147	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PDGFRA—melanoma	0.000143	0.000146	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FN1—melanoma	0.000142	0.000146	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL2—melanoma	0.000142	0.000145	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ALB—melanoma	0.000141	0.000145	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TERT—melanoma	0.000141	0.000145	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ITGB3—melanoma	0.000141	0.000145	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PRKCA—melanoma	0.000141	0.000145	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—HRAS—melanoma	0.000141	0.000144	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RAC1—melanoma	0.000141	0.000144	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—MAPK3—melanoma	0.00014	0.000143	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOTCH1—melanoma	0.000139	0.000143	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SPP1—melanoma	0.000139	0.000142	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAP2K2—melanoma	0.000138	0.000141	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—CXCL8—melanoma	0.000138	0.000141	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—BRAF—melanoma	0.000137	0.00014	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CD80—melanoma	0.000136	0.00014	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KIT—melanoma	0.000136	0.000139	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APC—melanoma	0.000136	0.000139	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CG—melanoma	0.000136	0.000139	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—NRAS—melanoma	0.000136	0.000139	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HIF1A—melanoma	0.000135	0.000138	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EGF—melanoma	0.000135	0.000138	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IGF1—melanoma	0.000134	0.000137	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—MAPK1—melanoma	0.000133	0.000136	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—EGFR—melanoma	0.000133	0.000136	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CG—melanoma	0.000132	0.000135	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL2—melanoma	0.000132	0.000135	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TERT—melanoma	0.000131	0.000134	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RAC1—melanoma	0.000131	0.000134	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—MAPK3—melanoma	0.00013	0.000133	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KDR—melanoma	0.000129	0.000132	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAP2K1—melanoma	0.000129	0.000132	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CD—melanoma	0.000128	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—BRAF—melanoma	0.000128	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PPARG—melanoma	0.000128	0.000131	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—PIK3CA—melanoma	0.000127	0.00013	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HIF1A—melanoma	0.000126	0.000128	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—KRAS—melanoma	0.000125	0.000128	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CB—melanoma	0.000125	0.000128	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IGF1—melanoma	0.000125	0.000128	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—AKT1—melanoma	0.000125	0.000127	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FN1—melanoma	0.000124	0.000127	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—MAPK1—melanoma	0.000124	0.000127	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—EGFR—melanoma	0.000124	0.000127	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTGS2—melanoma	0.000124	0.000127	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FGF2—melanoma	0.000123	0.000126	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOTCH1—melanoma	0.000122	0.000125	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAP2K1—melanoma	0.000121	0.000123	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KDR—melanoma	0.00012	0.000123	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CD—melanoma	0.00012	0.000123	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CD80—melanoma	0.000119	0.000122	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CG—melanoma	0.000119	0.000122	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APC—melanoma	0.000119	0.000122	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KIT—melanoma	0.000119	0.000122	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—NRAS—melanoma	0.000119	0.000122	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PIK3CA—melanoma	0.000119	0.000121	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EGF—melanoma	0.000118	0.00012	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—KRAS—melanoma	0.000117	0.00012	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CD—melanoma	0.000116	0.000119	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FN1—melanoma	0.000116	0.000118	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PIK3CA—melanoma	0.000115	0.000118	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MDM2—melanoma	0.000115	0.000117	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ALB—melanoma	0.000115	0.000117	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FGF2—melanoma	0.000115	0.000117	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—MAPK3—melanoma	0.000114	0.000117	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—ERBB2—melanoma	0.000113	0.000116	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOTCH1—melanoma	0.000113	0.000116	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—BRAF—melanoma	0.000112	0.000115	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CB—melanoma	0.000112	0.000114	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CD80—melanoma	0.000111	0.000113	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KIT—melanoma	0.000111	0.000113	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CG—melanoma	0.000111	0.000113	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APC—melanoma	0.000111	0.000113	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—NRAS—melanoma	0.000111	0.000113	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EGF—melanoma	0.000109	0.000112	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IGF1—melanoma	0.000109	0.000112	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—MAPK1—melanoma	0.000108	0.000111	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—EGFR—melanoma	0.000108	0.000111	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTEN—melanoma	0.000108	0.00011	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PIK3CA—melanoma	0.000108	0.00011	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CXCL8—melanoma	0.000107	0.00011	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MDM2—melanoma	0.000107	0.00011	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—HRAS—melanoma	0.000107	0.000109	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—MAPK3—melanoma	0.000106	0.000108	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—ERBB2—melanoma	0.000106	0.000108	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAP2K1—melanoma	0.000105	0.000108	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CDKN1B—melanoma	0.000105	0.000107	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CD—melanoma	0.000105	0.000107	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CB—melanoma	0.000104	0.000107	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—BRAF—melanoma	0.000104	0.000106	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—AKT1—melanoma	0.000104	0.000106	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	0.000104	0.000106	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CASP3—melanoma	0.000103	0.000105	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL2—melanoma	0.000103	0.000105	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—KRAS—melanoma	0.000102	0.000105	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—IL6—melanoma	0.000102	0.000104	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CB—melanoma	0.000101	0.000104	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IGF1—melanoma	0.000101	0.000104	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—MAPK1—melanoma	0.000101	0.000103	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—EGFR—melanoma	0.000101	0.000103	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS2—melanoma	0.0001	0.000103	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CXCL8—melanoma	0.0001	0.000103	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FGF2—melanoma	0.0001	0.000103	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CCND1—melanoma	0.0001	0.000102	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—HRAS—melanoma	9.96e-05	0.000102	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CTNNB1—melanoma	9.91e-05	0.000101	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CDKN1B—melanoma	9.79e-05	0.0001	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAP2K1—melanoma	9.79e-05	0.0001	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CD—melanoma	9.73e-05	9.95e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MMP9—melanoma	9.71e-05	9.94e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—AKT1—melanoma	9.69e-05	9.91e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CDKN1A—melanoma	9.68e-05	9.9e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PTEN—melanoma	9.65e-05	9.88e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	9.63e-05	9.86e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NFKB1—melanoma	9.61e-05	9.83e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CASP3—melanoma	9.6e-05	9.82e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL2—melanoma	9.58e-05	9.81e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—IL6—melanoma	9.54e-05	9.76e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—KRAS—melanoma	9.52e-05	9.74e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—AKT1—melanoma	9.42e-05	9.64e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	9.41e-05	9.63e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MDM2—melanoma	9.38e-05	9.59e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CCND1—melanoma	9.34e-05	9.56e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FGF2—melanoma	9.31e-05	9.53e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CTNNB1—melanoma	9.25e-05	9.47e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—ERBB2—melanoma	9.24e-05	9.46e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CB—melanoma	9.12e-05	9.34e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MMP9—melanoma	9.07e-05	9.28e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CDKN1A—melanoma	9.04e-05	9.25e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTEN—melanoma	9.02e-05	9.23e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NFKB1—melanoma	8.97e-05	9.18e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—AKT1—melanoma	8.8e-05	9e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CXCL8—melanoma	8.77e-05	8.97e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTEN—melanoma	8.76e-05	8.96e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	8.75e-05	8.95e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—VEGFA—melanoma	8.72e-05	8.92e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MDM2—melanoma	8.71e-05	8.91e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—HRAS—melanoma	8.71e-05	8.91e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—STAT3—melanoma	8.63e-05	8.83e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NRAS—melanoma	8.61e-05	8.81e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—ERBB2—melanoma	8.59e-05	8.79e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CDKN1B—melanoma	8.56e-05	8.76e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CB—melanoma	8.48e-05	8.67e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—AKT1—melanoma	8.47e-05	8.67e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CASP3—melanoma	8.39e-05	8.59e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL2—melanoma	8.38e-05	8.57e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—IL6—melanoma	8.34e-05	8.53e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAPK3—melanoma	8.25e-05	8.44e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CCND1—melanoma	8.17e-05	8.36e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CXCL8—melanoma	8.15e-05	8.34e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—VEGFA—melanoma	8.15e-05	8.33e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—HRAS—melanoma	8.09e-05	8.28e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CTNNB1—melanoma	8.09e-05	8.28e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—STAT3—melanoma	8.07e-05	8.25e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NRAS—melanoma	8.05e-05	8.23e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MYC—melanoma	8.02e-05	8.21e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CDKN1B—melanoma	7.96e-05	8.14e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP9—melanoma	7.93e-05	8.11e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CDKN1A—melanoma	7.9e-05	8.08e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTEN—melanoma	7.88e-05	8.07e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—AKT1—melanoma	7.87e-05	8.05e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MAPK1—melanoma	7.85e-05	8.03e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EGFR—melanoma	7.85e-05	8.03e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NFKB1—melanoma	7.85e-05	8.03e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CASP3—melanoma	7.8e-05	7.98e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL2—melanoma	7.78e-05	7.97e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—IL6—melanoma	7.75e-05	7.93e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAPK3—melanoma	7.71e-05	7.88e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—AKT1—melanoma	7.69e-05	7.87e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PIK3CA—melanoma	7.61e-05	7.79e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CCND1—melanoma	7.59e-05	7.77e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CTNNB1—melanoma	7.52e-05	7.69e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MYC—melanoma	7.49e-05	7.67e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—KRAS—melanoma	7.41e-05	7.59e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP9—melanoma	7.37e-05	7.54e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CDKN1A—melanoma	7.34e-05	7.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MAPK1—melanoma	7.33e-05	7.5e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EGFR—melanoma	7.33e-05	7.5e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTEN—melanoma	7.32e-05	7.49e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NFKB1—melanoma	7.29e-05	7.46e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—AKT1—melanoma	7.15e-05	7.31e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—VEGFA—melanoma	7.12e-05	7.29e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—STAT3—melanoma	7.05e-05	7.21e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NRAS—melanoma	7.03e-05	7.2e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—KRAS—melanoma	6.92e-05	7.09e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PIK3CA—melanoma	6.81e-05	6.97e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAPK3—melanoma	6.74e-05	6.89e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—VEGFA—melanoma	6.62e-05	6.77e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TP53—melanoma	6.59e-05	6.74e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MYC—melanoma	6.55e-05	6.7e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—STAT3—melanoma	6.55e-05	6.7e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NRAS—melanoma	6.54e-05	6.69e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MAPK1—melanoma	6.41e-05	6.56e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EGFR—melanoma	6.41e-05	6.56e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PIK3CA—melanoma	6.36e-05	6.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HRAS—melanoma	6.3e-05	6.45e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAPK3—melanoma	6.26e-05	6.4e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—AKT1—melanoma	6.22e-05	6.36e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PIK3CA—melanoma	6.18e-05	6.32e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TP53—melanoma	6.15e-05	6.3e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MYC—melanoma	6.09e-05	6.23e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—KRAS—melanoma	6.05e-05	6.19e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—IL6—melanoma	6.03e-05	6.17e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MAPK1—melanoma	5.96e-05	6.09e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EGFR—melanoma	5.95e-05	6.09e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HRAS—melanoma	5.89e-05	6.02e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—IL6—melanoma	5.63e-05	5.76e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—KRAS—melanoma	5.62e-05	5.76e-05	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—AKT1—melanoma	5.56e-05	5.69e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PIK3CA—melanoma	5.56e-05	5.69e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TP53—melanoma	5.38e-05	5.51e-05	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—AKT1—melanoma	5.2e-05	5.32e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PIK3CA—melanoma	5.17e-05	5.29e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HRAS—melanoma	5.15e-05	5.26e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—AKT1—melanoma	5.05e-05	5.17e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TP53—melanoma	5e-05	5.12e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—IL6—melanoma	4.92e-05	5.04e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HRAS—melanoma	4.78e-05	4.89e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—IL6—melanoma	4.58e-05	4.68e-05	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—AKT1—melanoma	4.54e-05	4.65e-05	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—AKT1—melanoma	4.22e-05	4.32e-05	CbGpPWpGaD
